Download PDF
1 / Pages

Other users also viewed these articles

Screening criteria for interstitial lung disease associated to rheumatoid arthritis: Expert proposal based on Delphi methodology Javier Narváez; Myriam Aburto; Daniel Seoane-Mato; Gema Bonilla; Orlando Acosta; Gloria Candelas; Esteban Cano-Jiménez; Iván Castellví; José María González-Ruiz; Héctor Corominas; Belén López-Muñiz; María Martín-López; Alejandro Robles-Pérez; Natalia Mena-Vázquez; José Antonio Rodríguez-Portal; Ana María Ortiz; Cristina Sabater-Abad; Isabel Castrejón; Raquel dos Santos; Sandra Garrote-Corral; Jesús Maese; Lucía Silva-Fernández; Santos Castañeda; Claudia Valenzuela;
Reumatol Clin. 2023;19:74-81
SER-SEPAR recommendations for the management of rheumatoid arthritis-related interstitial lung disease. Part 1: Epidemiology, risk factors and prognosis José Antonio Rodríguez Portal; Noé Brito García; Petra Díaz del Campo Fontecha; Claudia Valenzuela; Ana María Ortiz; M. Asunción Nieto; Natalia Mena-Vázquez; Esteban Cano-Jiménez; Iván Castellví; Myriam Aburto; Gema Bonilla; María Vanesa Hernández Hernández; Félix Manuel Francisco Hernández; María Correyero Plaza; Isabel Castrejón; Miguel Ángel Abad Hernández; Javier Narváez;
Reumatol Clin. 2022;18:443-52
CXCL10 as a biomarker of interstitial lung disease in patients with rheumatoid arthritis Yasmine S. Makarem; Elzahraa A. Ahmed; Marwa Makboul; Shimaa Farghaly; Naima Mostafa; Randa A. El Zohne; Samar H. Goma;
Reumatol Clin. 2024;20:1-7